Filter Search for grants
Call Navigation
Deadline expired
The deadline for this call has expired.
Call key data
EIT Health Flagships Call 2025
Funding Program
European Institute of Innovation and Technology
deadlines
Opening
05.09.2024
Deadline
05.11.2024 23:00
Call budget
€ 8,000,000.00
Link to the call
Link to the submission
Call content
short description
In 2025, the Call will address the Digital Transformation of Healthcare (DTH). This Flagship concept aims to support the digital health transformation in Europe and will focus on the development of, and access to, health technologies and digital medical devices. It will finally focus on how patients, citizens, and healthcare professionals are trained to understand the importance and relevance of data sharing in informing and improving the continuum of care pathways.
Call objectives
For 2025 specifically, funded activities under the DTH Flagship will focus on the development and market uptake of patient-centred digital health solutions. There will also be a focus on ensuring innovation adoption through the selection of modules to equip professionals with relevant knowledge and skills.
Innovation to Market Projects will focus on supporting the entry of digital medical devices, that are already CE-marked or awaiting CE approval, into one or more EU country market(s), by generating robust evidence of the solution’s relevance in the target market and building commercial partnerships to drive market uptake.
The DiGinnovation Programme is specifically tailored for micro and small enterprises with CE-marked digital health solutions that are looking for support to achieve reimbursement coverage.
Modules towards EIT Labelled Certification to further enrich the EIT Health catalogue of courses that support the Flagship ‘Digital Health Transformation’, EIT Health is calling for high-quality content that will feed into modules on the EIT Health Academy.
EIT Health is looking for collaborators who will support the organisation and hosting of the EIT Health Catapult programme 2025. This is a competition and training programme to fast-track top life sciences and health tech start-ups and showcase them to leading experts and investors across Europe.
Please find below the list of activities:
- Innovation activities
- Education activities
- Accelerator programme
read more
Expected results
For educational activities:
- Course outline with clear expected learning outcomes mapped on selected competences from the EIT Health Competence Framework and EIT overarching learning outcomes (OLO’s).
- Content developed on the above for a 4-week (up to 15/20 hours of study in total) online course, that will be hosted entirely on the EIT Health Academy. The Academy team will support selected consortia from the selection notification.
- Content toward assessment, for example, scenario-based assessment, multiple choice questions, etc.
More information can be found on pages 9-20 of the call document.
EIT Health Catapult:
The EIT Health Catapult is a training program for Health-Tech and Life Sciences start-ups. Through dedicated sessions, up to 30 ambitious start-ups optimise their business plan, strengthen their pitch deck and present themselves in front of international investors and corporates. At the end of the training, 9 finalists, selected by an independent expert jury of investors, join the world’s leading health market community for a live on-stage competition at a major Health-Tech conference in Europe.
The programme is organised into three defined stages:
- Regional Selections: In this stage, the top start-ups from each region (EIT Health CLC regions) are chosen across two categories—Life Sciences and Health-Tech (which includes Med-Tech and Digital Health). The two leading Health-Tech start-ups and the top Life Sciences start-up from each region advance to the semi-final stage.
- Semi-finals: Training and Selection Days: the best European start-ups in each category are selected by an international panel of healthcare investors. This stage includes 2-3 days of online training with mentors and pitch trainers. On pitch day, 10 start-ups from Life Sciences and 20 from Health-Tech present in front of top-level investors and industry experts, with the top 9 (3 in Life Sciences, 6 in Health-Tech) moving on to the final. At this stage an in-person get-together is organised to connect start-ups with investors, industry, hospitals and other stakeholders. In addition, an online platform to showcase the current participants of the programme to investors and the European healthcare ecosystem is set up and managed.
- International Finals: The final pitch stage takes place during a major health related event in Europe. An international jury of investors selects one winner per category. Each winner receives prize money from EIT Health. Additionally, the audience can vote to award one finalist with the Audience Award and industry partners award the industry in-kind prizes (i.e., technical cloud infrastructure, opportunity to pilot their solution in a clinical environment, exposure to relevant departments, etc.).
More details can be found on pages 21-25 of the call document.
Innovation activities:
Specific conditions for Innovation to Market Projects in DTH:
Through this call, EIT Health aims to support the transformation, harmonisation and strengthening of the use ofDigital Medical Devides (DMDs) across European healthcare systems. We are calling for collaborative SME- or industry-led projects with a duration of maximum 10 months, that focus on new market entry and commercial piloting activities for patient-centred DMDs to facilitate and accelerate their implementation and wider adoption across EU markets.
EIT Health seeks proposals for Innovation to Market projects (max. 10 months long) for DMDs that have either already obtained CE approval or are awaiting CE approval (in this case, a CE mark dossier must have been submitted to a notified body at least 6 months prior to the proposal submission), and that are aiming to generate further evidence to enter new European markets. The focus here is on generating robust data to support health economics arguments, improve market access conditions, and strengthen the commercial viability of providers of digital health solutions in these markets.
The proposed digital health solution must be at an Innovation Maturity Level (IML) of between IML 7 (Validation of Solution) and IML 8 (Approval & Launch) at the time of the proposal submission and be preparing for entry into a new market within the activity timeframe.
More details can be found on pages 27-32 of the call document.
Specific conditions for DiGinnovation programme:
The DiGinnovation programme selects the top digital health micro and small enterprises as part of a consortium that will improve healthcare systems by accelerating the uptake of digital medical devices by healthcare professionals and patients and expediting market launch of the innovation while easing the reimbursement process.
The focus of this programme is on supporting patient-centred Digital Medical Devices on their way to reach reimbursement in a European healthcare system. Digital Medical Devices (DMDs) are health technologies falling into the definition of medical devices as outlined in the Regulation (EU) 2017/745 and which main function is based on digital technologies intended to support one or more of the following medical purposes:
- diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease;
- diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury or disability;
- investigation, replacement or modification of the anatomy or of a physiological or pathological process or state; and / or,
- providing information by means of in vitro examination of specimens derived from the human body, including organ, blood and tissue donations.
The proposed digital health solution must be at an Innovation Maturity Level (IML) of between IML 7 (Validation of Solution) and IML 8 (Approval & Launch) at the time of the proposal submission to advance to IML9 (Clinical Use) maximum 1 year after the project end date.
More details can be found on pages 33-35 of the call document.
read more
Eligibility Criteria
Regions / countries for funding
Moldova (Moldova), Albania (Shqipëria), Armenia (Հայաստան), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Faeroes (Føroyar / Færøerne), Georgia (საქართველო), Iceland (Ísland), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Montenegro (Црна Гора), Morocco (المغرب), New Zealand (Aotearoa), North Macedonia (Северна Македонија), Norway (Norge), Serbia (Srbija/Сpбија), Switzerland (Schweiz/Suisse/Svizzera), Tunisia (تونس /Tūnis), Türkiye, Ukraine (Україна), United Kingdom
eligible entities
EU Body, Education and training institution, International organization, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
Yes
Project Partnership
For educational activities:
- The consortium must include at least two participants coming from two different and independent institutions.
- Each consortium must include participants residing in at least two eligible countries, participating through two different Co-Location Centres (CLCs).
- Each consortium must involve organisations from two sides of the Knowledge Triangle, e.g. industry and healthcare provider, higher education institution and industry, etc.
- Applications must commit to the EIT Health Competence Framework and EIT Health label /accreditation for non-degree programmes.
- Validated expertise in the Flagship topics and application for the European Union of Medical Specialists (UEMS) European Accreditation Council for Continuing Medical Education (EACCME) accreditation (where healthcare professionals are the target audience) are expected.
- The final recipients of funding must comply with the Intellectual Property Rights (IPR) rules under the MGA Article 16.
- Funding per module: up to 50,000.00€
- Reimbursement rate: 70%
- The grant covers the activity until the delivery of the module(s) by latest 12 December 2025.
For the EIT Health Catapult:
- The consortium must include at least two participants coming from two different and independent institutions.
- Each consortium must have at least one EIT Health member of the association as part of the consortium (Core or Associate Partner).
- Each consortium must include participants residing in at least two eligible countries, participating through two different Co-Location Centres (CLCs).
- Each consortium must contribute to the European Green Deal and the Sustainable Development Goals (SDGs). Therefore, they should add at least one customised KPI that proves how they contribute to the reduction of the environmental impact of their activity and at least 2 SDGs that the activity will contribute to.
- Each consortium must contribute to the EIT and EIT Health Dissemination and Promotion, and must follow the communication, dissemination, open science and visibility rules, including branding guidelines and obligations (set out in MGA Article 17). A communication, dissemination and outreach plan is required for each activity, including those providing financial support to third parties.
- The final recipients of funding must comply with the Intellectual Property Right (IPR) rules under the MGA Article 16.
- The total budget of the programme shall not exceed 380,000 EUR (three hundred eighty thousand Euros) excluding EIT Health costs.
- The following costs will be covered by EIT Health and should not be included in the proposed consortium budget:
- Sub-contracting of experts (legal, mentors, pitch trainers, evaluators, jury members, etc.);
o Sub-granting to Start-ups (T&A and prize money);
o Costs to run the call for start-ups and the regional selections.
- Sub-contracting of experts (legal, mentors, pitch trainers, evaluators, jury members, etc.);
- Co-Funding: The recommended, though not mandatory, co-funding contribution for this activity is 20%.
- The grant covers the activity from 1 May 2025 until 31 July 2026.
For Innovation activities:
- The consortium must include at least two participants coming from two different and independent institutions.
- Each consortium must have at least one EIT Health member of the association as part of the consortium (Core or Associate Partner).
- Each consortium must include participants residing in at least two eligible countries, participating through two different Co-Location Centres (CLCs).
- Each consortium must involve organisations from two sides of the Knowledge Triangle, e.g. industry and healthcare provider, higher education institution and industry, etc.
- Each consortium must contribute to the European Green Deal and the Sustainable Development Goals (SDGs). Therefore, they should add at least one customised KPI that proves how they contribute to the reduction of the environmental impact of their activity and at least 2 SDGs that the activity will contribute to.
- Each consortium must contribute to the EIT and EIT Health Dissemination and Promotion, and must follow the communication, dissemination, open science and visibility rules, including branding guidelines and obligations (set out in MGA Article 17). A communication, dissemination and outreach plan is required for each activity, including those providing financial support to third parties.
- The final recipients of funding must comply with the Intellectual Property Right (IPR) rules under the MGA Article 16.
- Every consortium must include a designated “commercialising entity” listed in the participants section of the application form.
- The following requirements and definitions shall apply in the case of micro and small enterprises applying as a commercialising entity:
- The entity is a for-profit micro or small enterprise according to the EU definition,
- The entity must have at least 4 paid FTEs (Full Time Equivalent) working at the time of the proposal submission. The entity must have a CEO working full-time in the company at the time of the proposal submission, where full-time refers to the legally mandated number of hours for a full-time occupation in the country where the entity is incorporated.
- The entity cannot have publicly traded shares or gone through an IPO.
- For Innovation to Market Projects in DTH, the following additional criteria apply:
- The commercialising entity can be a start-up or micro-small enterprise, a medium or large-sized industry player, a healthcare provider, or any type of organisation that will be responsible for bringing the product to market and commercialising it.
- The activity must request a minimum of 500,000 EUR (five hundred thousand Euros) EIT Health funding.
- The maximum grant that can be requested by the consortium is 1,000,000 EUR (one million Euros) for the total duration of the activity.
- A co-funding rate of 30% for the whole duration of the activity is required.
- The maximum duration of EIT Health financial support is 10 months. The grant covers the activity until 31 December 2025, at the latest.
- For the DiGinnovation programme:
- The lead partner and commercialising entity is a micro or small enterprise.
- The maximum grant that can be requested by the consortium is 350,000 EUR (three hundred fifty thousand Euros) for the total duration of the activity, of which a minimum grant of 150,000 EUR (one hundred fifty thousand Euros) must be requested by the micro or small enterprise.
- The maximum funding rate is 70% among the whole activity’s duration (30% co-funding required).
- The maximum duration of EIT Health financial support is 10 months. The grant covers the activity until 31 December 2025, at the latest.
other eligibility criteria
- This call follows the principle of equal opportunity, and is therefore open to applications for funding from both EIT Health association members and applicants outside of the EIT Health Partnership.
- To be eligible for funding, all applicants must be established in one of the Member States (MS) including their outermost regions, the Overseas Countries and Territories linked to the Member States or in countries associated to Horizon Europe as well as certain low- and middle-income countries.
- Individuals cannot apply for funding under this call.
- Non-EIT Health members will only be eligible to receive funding after they have acceded to the relevant EIT Health legal framework.
- The provisions of the Articles of Association and By-Laws of the EIT Health association (EIT Health e.V) will apply to partners of selected activity consortiums. All project participants of funded EIT Health projects must adhere to the EIT Health Fee Model. For more information on the fee model please check our website section here.
- The maximum amount of financial support provided to individual entities within the 3-year duration of the Grant Agreement between EIT Health and EIT, namely 2023-2025 should not exceed EUR 6,000,000.
The call aims to fund up to 7 Innovation projects, distributed across Innovation to Market Projects and the DiGinnovation programme, covering different clinical areas and unmet needs. Furthermore, the call intends to fund up to 19 education modules addressed to specific target audiences, offered through the EIT Health Academy. Moreover, the call is also looking at funding one consortium that will be responsible for delivering the longest-standing initiative in the accelerator – The EIT Health Catapult Programme.
Additional information
Topics
Relevance for EU Macro-Region
EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region
UN Sustainable Development Goals (UN-SDGs)
Additional Information
The application will be done through the EIT Health Application Platform. New applicants will need to register on the application platform.
If the applicant is already an EIT Health member, or has registered as an External project Partner in previous Call(s) on our platform PLAZA, the corresponding data for the organisation will be available in the application platform.
However, the applicant will still need to create a new account as an individual and link themselves to their organisation.
The approval of this link might take up to 48 hours and extra information on the organisation profile might be requested.
Call documents
EIT Health Flagship Call 2025 - call documentEIT Health Flagship Call 2025 - call document(618kB)
Contact
To see more information about this call, you can register for free here
or log in with an existing account.
Log in
Register now